| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00026 | 1 |